Back to Journals » Vascular Health and Risk Management » Volume 9 » default

Vascular Health and Risk Management

ISSN: 1178-2048


Archive: Volume 9, 2013

Serum lipid profile and correlates in newly presenting Nigerians with arterial hypertension

Adamu UG, Okuku GA, Oladele CO, Abdullahi A, Oduh JI, Fasae AJ

Vascular Health and Risk Management 2013, 9:763-768

Published Date: 3 December 2013

Vitamin E tocotrienol supplementation improves lipid profiles in chronic hemodialysis patients

Daud ZAM, Tubie B, Sheyman M, Osia R, Adams J, Tubie S, Khosla P

Vascular Health and Risk Management 2013, 9:747-761

Published Date: 28 November 2013

Visceral obesity is not an independent risk factor of mortality in subjects over 65 years

Thomas F, Pannier B, Benetos A, Vischer UM

Vascular Health and Risk Management 2013, 9:739-745

Published Date: 22 November 2013

Vitamin D deficiency is associated with development of subclinical coronary artery disease in HIV-infected African American cocaine users with low Framingham-defined cardiovascular risk

Lai H, Fishman EK, Gerstenblith G, Moore R, Brinker JA, Keruly JC, Chen S, Detrick B, Lai S

Vascular Health and Risk Management 2013, 9:729-737

Published Date: 15 November 2013

Changes in LDL-C levels and goal attainment associated with addition of ezetimibe to simvastatin, atorvastatin, or rosuvastatin compared with titrating statin monotherapy

Foody JM, Toth PP, Tomassini JE, Sajjan S, Ramey DR, Neff D, Tershakovec AM, Hu H, Tunceli K

Vascular Health and Risk Management 2013, 9:719-727

Published Date: 15 November 2013

Lipid profiles and inflammatory markers after periodontal treatment in children with congenital heart disease and at risk for atherosclerosis

Bresolin AC, Pronsatti MM, Pasqualotto LN, Nassar PO, Jorge AS, Silva EA, Nassar CA

Vascular Health and Risk Management 2013, 9:703-709

Published Date: 11 November 2013

Titration of amlodipine to higher doses: a comparison of Asian and Western experience

Kario K, Robbins J, Jeffers BW

Vascular Health and Risk Management 2013, 9:695-701

Published Date: 5 November 2013

Linagliptin as add-on therapy to insulin for patients with type 2 diabetes

von Websky K, Reichetzeder C, Hocher B

Vascular Health and Risk Management 2013, 9:681-694

Published Date: 1 November 2013

Postmarketing safety experience with edoxaban in Japan for thromboprophylaxis following major orthopedic surgery

Kuroda Y, Hirayama C, Hotoda H, Nishikawa Y, Nishiwaki A

Vascular Health and Risk Management 2013, 9:593-598

Published Date: 7 October 2013

Left ventricular dysfunction in normotensive type II diabetic patients in Port Harcourt, Nigeria

Dodiyi-Manuel ST, Akpa MR, Odia OJ

Vascular Health and Risk Management 2013, 9:529-533

Published Date: 25 September 2013

Serum calcium levels are not associated with coronary heart disease

Jin Y, He L, Wang Q, Chen Y, Ren X, Tang H, Song X, Ding L, Qi Q, Huang Z, Yu J, Yao Y

Vascular Health and Risk Management 2013, 9:517-520

Published Date: 3 September 2013

Increased burden and severity of metabolic syndrome and arterial stiffness in treatment naïve HIV+ patients from Cameroon

Ngatchou W, Lemogoum D, Ndobo P, Yagnigni E, Tiogou E, Nga E, Kouanfack C, van de Borne P, Hermans MP

Vascular Health and Risk Management 2013, 9:509-516

Published Date: 4 September 2013

Spanish translation, cross-cultural adaptation, and validation of the Questionnaire for Diabetes-Related Foot Disease (Q-DFD)

Castillo-Tandazo W, Flores-Fortty A, Feraud L, Tettamanti D

Vascular Health and Risk Management 2013, 9:501-508

Published Date: 28 August 2013

Vitamin D deficiency is associated with coronary artery calcification in cardiovascularly asymptomatic African Americans with HIV infection

Lai S, Fishman EK, Gerstenblith G, Brinker J, Tai H, Chen S, Li J, Tong W, Detrick B, Lai H

Vascular Health and Risk Management 2013, 9:493-500

Published Date: 26 August 2013

Perceptions of barriers to cardiac rehabilitation use in Brazil

Ghisi GLM, Santos RZ, Aranha EE, Nunes AD, Oh P, Benetti M, Grace SL

Vascular Health and Risk Management 2013, 9:485-491

Published Date: 30 August 2013

Safety, tolerability, and efficacy of a fixed-dose combination of olmesartan 40 mg and hydrochlorothiazide 12.5/25 mg in daily practice

Bramlage P, Zemmrich C, Ketelhut R, Wolf WP, Fronk EM, Schmieder RE

Vascular Health and Risk Management 2013, 9:475-483

Published Date: 26 August 2013

Current status of NADPH oxidase research in cardiovascular pharmacology

Rodiño-Janeiro BK, Paradela-Dobarro B, Castiñeiras-Landeira MI, Raposeiras-Roubín S, González-Juanatey JR, Álvarez E

Vascular Health and Risk Management 2013, 9:401-428

Published Date: 25 July 2013

The COSEHC™ Global Vascular Risk Management quality improvement program: first follow-up report

Ferrario CM, Joyner J, Colby C, Exuzides A, Moore M, Simmons D, Bestermann Jr W, Frech-Tamas F

Vascular Health and Risk Management 2013, 9:391-400

Published Date: 22 July 2013

Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension

Maki KC, Rains TM, Schild AL, Dicklin MR, Park KM, Lawless AL, Kelley KM

Vascular Health and Risk Management 2013, 9:369-379

Published Date: 23 July 2013

Neutrophil/lymphocyte ratio in patients with atrial septal aneurysm

Demir M, Demir C

Vascular Health and Risk Management 2013, 9:365-368

Published Date: 19 July 2013

Hyperhomocysteinemia and vascular access thrombosis in hemodialysis patients: a retrospective study

Saifan C, El-Charabaty E, El-Sayegh S

Vascular Health and Risk Management 2013, 9:361-364

Published Date: 17 July 2013

Pattern of sudden death at Ladoke Akintola University of Technology Teaching Hospital, Osogbo, South West Nigeria

Akinwusi PO, Komolafe AO, Olayemi OO, Adeomi AA

Vascular Health and Risk Management 2013, 9:333-339

Published Date: 24 June 2013

Aldosterone receptor antagonists: current perspectives and therapies

Guichard JL, Clark III D, Calhoun DA, Ahmed MI

Vascular Health and Risk Management 2013, 9:321-331

Published Date: 24 June 2013

Statins in heart failure: do we need another trial?

Bonsu KO, Kadirvelu A, Reidpath DD

Vascular Health and Risk Management 2013, 9:303-319

Published Date: 17 June 2013

Persistent middle cerebral artery occlusion associated with lower body temperature on admission

Kvistad CE, Øygarden H, Thomassen L, Waje-Andreassen U, Naess H

Vascular Health and Risk Management 2013, 9:297-302

Published Date: 17 June 2013

Management of dyslipidemia and hyperglycemia with a fixed-dose combination of sitagliptin and simvastatin

Steinberg H, Anderson MS, Musliner T, Hanson ME, Engel SS

Vascular Health and Risk Management 2013, 9:273-282

Published Date: 29 May 2013

Current and future initiatives for vascular health management in clinical practice

Cameron JD, Asmar R, Struijker-Boudier H, Shirai K, Sirenko Y, Kotovskaya Y, Topouchian J

Vascular Health and Risk Management 2013, 9:255-264

Published Date: 28 May 2013

Red blood cell count as an indicator of microvascular complications in Chinese patients with type 2 diabetes mellitus

Wang ZS, Song ZC, Bai JH, Li F, Wu T, Qi J, Hu J

Vascular Health and Risk Management 2013, 9:237-243

Published Date: 14 May 2013

Effects of CPAP on "vascular" risk factors in patients with obstructive sleep apnea and arterial hypertension

Litvin AY, Sukmarova ZN, Elfimova EM, Aksenova AV, Galitsin PV, Rogoza AN, Chazova IE

Vascular Health and Risk Management 2013, 9:229-235

Published Date: 10 May 2013

Potential role of new anticoagulants for prevention and treatment of venous thromboembolism in cancer patients

Gómez-Outes A, Suárez-Gea ML, Lecumberri R, Terleira-Fernández AI, Vargas-Castrillón E, Rocha E

Vascular Health and Risk Management 2013, 9:207-228

Published Date: 8 May 2013

Endoglin: a critical mediator of cardiovascular health

Kapur NK, Morine KJ, Letarte M

Vascular Health and Risk Management 2013, 9:195-206

Published Date: 6 May 2013

Platelet function testing to predict hyporesponsiveness to clopidogrel in patients with chest pain seen in the emergency department

Sharma RK, Erickson SW, Sharma R, Voelker DJ, Reddy HK, Dod H, Marsh JD

Vascular Health and Risk Management 2013, 9:187-193

Published Date: 1 May 2013

Stress-induced cardiomyopathy (Takotsubo) – broken heart and mind?

Redfors B, Shao Y, Omerovic E

Vascular Health and Risk Management 2013, 9:149-154

Published Date: 17 April 2013

Short-term outcome of patients with preeclampsia

Koual M, Abbou H, Carbonnel M, Picone O, Ayoubi JM

Vascular Health and Risk Management 2013, 9:143-148

Published Date: 15 April 2013

Antihypertensive therapy: nocturnal dippers and nondippers. Do we treat them differently?

Mahabala C, Kamath P, Bhaskaran U, Pai ND, Pai AU

Vascular Health and Risk Management 2013, 9:125-133

Published Date: 24 March 2013

The influence of perivascular adipose tissue on vascular homeostasis

Szasz T, Bomfim GF, Webb RC

Vascular Health and Risk Management 2013, 9:105-116

Published Date: 28 March 2013

Comparison between oscillometric- and Doppler-ABI in elderly individuals

Takahashi I, Furukawa K, Ohishi W, Takahashi T, Matsumoto M, Fujiwara S

Vascular Health and Risk Management 2013, 9:89-94

Published Date: 8 March 2013

Adverse drug events associated with vitamin K antagonists: factors of therapeutic imbalance

El-Helou N, Al-Hajje A, Ajrouche R, Awada S, Rachidi S, Zein S, Salameh P

Vascular Health and Risk Management 2013, 9:81-88

Published Date: 1 March 2013

Lipid management in 13,000 high risk cardiovascular patients treated under daily practice conditions: LIMA Registry

Schaefer JR, Gitt AK, Sonntag F, Weizel A, Jannowitz C, Karmann B, Pittrow D, Bestehorn K

Vascular Health and Risk Management 2013, 9:71-80

Published Date: 21 February 2013

Comparative effect of clopidogrel plus aspirin and aspirin monotherapy on hematological parameters using propensity score matching

Hayasaka M, Takahashi Y, Nishida Y, Yoshida Y, Hidaka S, Asai S

Vascular Health and Risk Management 2013, 9:65-70

Published Date: 18 February 2013

Clinical evidence and mechanistic basis for vildagliptin's effect in combination with insulin

Schweizer A, Foley JE, Kothny W, Ahrén B

Vascular Health and Risk Management 2013, 9:57-64

Published Date: 15 February 2013

Metabolic biomarkers for predicting cardiovascular disease

Montgomery JE, Brown JR

Vascular Health and Risk Management 2013, 9:37-45

Published Date: 29 January 2013

Heel-rise test in the assessment of individuals with peripheral arterial occlusive disease

Monteiro DP, Britto RR, Lages AC, Basílio ML, Pires MC, Carvalho ML, Procópio RJ, Pereira DA

Vascular Health and Risk Management 2013, 9:29-35

Published Date: 23 January 2013

Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment

Lukashevich V, Schweizer A, Foley JE, Dickinson S, Groop PH, Kothny W

Vascular Health and Risk Management 2013, 9:21-28

Published Date: 23 January 2013

Atrial fibrillation and thromboprophylaxis in heart failure: the need for patient-centered approaches to address adherence

Ferguson C, Inglis SC, Newton PJ, Middleton S, Macdonald PS, Davidson PM

Vascular Health and Risk Management 2013, 9:3-11

Published Date: 17 January 2013

Corrigendum

Basit A, Riaz M, Fawwad A

Vascular Health and Risk Management 2013, 9:1-2

Published Date: 27 December 2012